ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Presentations Articles

Systemic inflammatory response in cardiogenic shock patients randomized to microaxial flow pump or standard care in the DanGer-Shock trial

Event: ESC Congress 2025

Topic: Shock

Session: Cardiogenic shock in acute coronary syndromes

Impact of oxygenations targets on inflammation after out-of-hospital cardiac arrest in males and females - a substudy of the BOX trial

Event: ESC Acute CardioVascular Care 2025

Topic: Cardiac Arrest

Session: Research Prize

Influence of blood pressure targets on inflammation and associations between inflammatory markers and vasopressor usage after cardiac arrest - a substudy of a randomized clinical trial

Event: ESC Congress 2024

Topic: Cardiac Arrest

Session: Innovations in cardiac arrest

Performance of neuron-specific enolase and neurofilament light chain in predicting death after hospital admittance from out-of-hospital cardiac arrest - A sub study of the IMICA trial

Event: ESC Acute CardioVascular Care 2022

Topic: Biomarkers

Session: Cardiac arrest, rhythm and other

Tocilizumab mitigates hypercoagulability after out-of-hospital cardiac arrest - results from a randomized controlled trial (IMICA)

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Arrest

Session: Frontiers in the diagnosis and management of cardiac arrest

Tocilizumab reduces cardiac injury after out-of-hospital cardiac arrest primarily in patients without acute revascularization - Results from a randomized trial, The IMICA trial

Event: ACVC 2021

Topic: Cardiac Arrest

Session: Live Abstract session - Cardiopulmonary resuscitation

ESC 365 is supported by

novartis

Explore sponsored resources